Toray Industries, Inc.
Toray Industries, Inc. (3402.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Toray Industries, Inc. (3402.T), covering cash flow, earnings, and balance sheets.
Toray Industries, Inc. (3402.T) Income Statement & Financial Overview
Review Toray Industries, Inc. 3402.T income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $639.38B | $629.79B | $656.38B | $637.73B |
Cost of Revenue | $513.81B | $507.51B | $524.89B | $511.18B |
Gross Profit | $125.57B | $122.28B | $131.50B | $126.55B |
Gross Profit Ratio | $0.20 | $0.19 | $0.20 | $0.20 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $93.77B | $92.76B | $89.62B | $89.96B |
Operating Expenses | $93.77B | $92.76B | $89.62B | $89.96B |
Total Costs & Expenses | $607.58B | $600.27B | $614.51B | $601.13B |
Interest Income | $1.29B | $3.28B | $1.33B | $5.19B |
Interest Expense | $7.33B | $3.27B | $6.57B | $4.74B |
Depreciation & Amortization | $31.53B | $32.61B | $32.22B | $32.74B |
EBITDA | $56.45B | $56.91B | $73.66B | $70.81B |
EBITDA Ratio | $0.09 | $0.09 | $0.11 | $0.11 |
Operating Income | $31.80B | $29.52B | $41.87B | $36.59B |
Operating Income Ratio | $0.05 | $0.05 | $0.06 | $0.06 |
Other Income/Expenses (Net) | -$14.21B | -$5.20B | -$5.92B | $5.21B |
Income Before Tax | $17.59B | $24.32B | $35.96B | $38.52B |
Income Before Tax Ratio | $0.03 | $0.04 | $0.05 | $0.06 |
Income Tax Expense | $2.29B | $8.05B | $5.28B | $12.00B |
Net Income | $2.73B | $19.65B | $28.66B | $26.86B |
Net Income Ratio | $0.004 | $0.03 | $0.04 | $0.04 |
EPS | $1.74 | $12.30 | $17.86 | $16.77 |
Diluted EPS | $1.74 | $12.31 | $17.85 | $16.74 |
Weighted Avg Shares Outstanding | $1.57B | $1.60B | $1.60B | $1.60B |
Weighted Avg Shares Outstanding (Diluted) | $1.57B | $1.60B | $1.61B | $1.60B |
Over the past four quarters, Toray Industries, Inc. demonstrated steady revenue growth, increasing from $637.73B in Q1 2024 to $639.38B in Q4 2024. Operating income reached $31.80B in Q4 2024, maintaining a consistent 5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $56.45B, reflecting operational efficiency. Net income dropped to $2.73B, with EPS at $1.74. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan